TABLE 1.
Demographic characteristics of patients with chronic wounds.
| Number of wounds | Number of patients (ulcer) | Age (years), Sex | Comorbidities | Type of ulcer | Localisation of wound | Date of start | Date of end | Duration of observation (days) | Number of measurements |
|---|---|---|---|---|---|---|---|---|---|
| 1 | 1 | 37, M | DM t.1 | N | F | 2022‐04‐11 | 2023‐06‐15 | 66 | 5 |
| 2 | 2 | 71, F | CVI | V | LL | 2022‐04‐20 | LTFU | 1 | 1 |
| 3 | 3 | 81, F | CVI, LC | M | LL | 2022‐11‐03 | 2023‐01‐05 | 65 | 10 |
| 4 | 4 | 83, F | CVI | V | LL | 2022‐11‐08 | 2022‐11‐15 | 7 | 2 |
| 5 | 5 (u1) | 93, F | CVI, HT, DM t.2, HypoT | M | LL | 2022‐11‐21 | 2023‐02‐16 | 88 | 5 |
| 6 | 5 (u2) | 93, F | CVI, HT, DM t.2, HypoT | M | LL | 2022‐11‐21 | 2023‐02‐16 | 88 | 5 |
| 7 | 6 | 72, F | CVI, HT, DM t.2, HypoT | V | LL | 2022‐11‐28 | 2022‐12‐05 | 7 | 2 |
| 8 | 7 | 76, F | CVI, HT, DM t.2 | V | LL | 2022‐12‐05 | LTFU | 1 | 1 |
| 9 | 8 | 75, F | CVI, HT, AT | M | LL | 2022‐12‐06 | 2022‐12‐14 | 8 | 2 |
| 10 | 9 | 52, M | DM t.2 | N | F | 2022‐12‐07 | LTFU | 1 | 1 |
| 11 | 10 | 51, M | CVI | V | LL | 2022‐12‐14 | 2023‐02‐14 | 63 | 4 |
| 12 | 11 (u1) | 60, M | CVI | V | LL | 2022‐12‐07 | 2023‐02‐15 | 77 | 17 |
| 13 | 11 (u2) | 60, M | CVI | V | LL | 2022‐12‐12 | 2023‐02‐15 | 70 | 16 |
| 14 | 11 (u3) | 60, M | CVI | V | LL | 2022‐12‐12 | 2023‐02‐15 | 70 | 16 |
| 15 | 11 (u4) | 60, M | CVI | Ac | LL | 2023‐01‐05 | 2023‐01‐11 | 7 | 3 |
| 16 | 11 (u5) | 60, M | CVI | Ac | LL | 2023‐01‐11 | 2023‐01‐13 | 4 | 2 |
| 17 | 11 (u6) | 60, M | CVI | Ac | LL | 2023‐01‐11 | 2023‐01‐27 | 16 | 4 |
| 18 | 11 (u7) | 60, M | CVI | V | LL | 2023‐03‐22 | 2023‐04‐19 | 28 | 8 |
Note: (a) Sex: F, female; M, male. (b) Comorbidities: CVI, chronic vein insufficiency; HT, hypertension; DM t.1/t.2, diabetes mellitus type 1/type 2; HypoT, hypothyroidism; AT, atherosclerosis; LC, lung cancer. (c) Type of ulcer: N, neuropathic; V, venous; M, mixed; Ac, acute. (d) Localisation: F, foot; LL, lower leg. (e) LTFU, lost to follow up.